The ASX's 3 pathology stocks: Sonic Healthcare (ASX:SHL), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL); have delivered a torrid experience for shareholders over the past two to three years.
Sonic, the…
Australian Clinical Labs fell 10% today after revenue went slightly backwards, even though underlying profit improved.
The key nuance is that management deliberately walked away from low margin collection centres and…
We often like to look at shares that well known ASX fund managers are trading, and today we're looking at a few stocks that Australian Ethical bought or sold recently.
Australian…
The Healius ACL merger appears all but dead now that the ACCC blocked the plans. Even so, it was on shaky grounds long before the competition regulator showed its scepticism…
Yesterday we looked at bad ASX IPOs (and some foreign ones too) that bounced back. The lesson we hoped investors would draw is that all hope is not lost when…
Ageing population stocks represent among the best long-term opportunities that exist for investors.
Over the next 25 years, the world's population of people over 60 will double.
Looking specifically at Australia, the…